Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02904278 · ClinicalTrials.gov registry record · NA

Novel Mobile Device Application to Improve Adherence

A NA study, sponsored by National Institute of Allergy and Infectious Diseases (NIAID).

Completed
Registry status
NA
Development phase
26
Enrollment target

NCT02904278 is a NA study that has completed, run by National Institute of Allergy and Infectious Diseases (NIAID). The registered enrollment target is 26 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02904278, a NA study, has completed, sponsored by National Institute of Allergy and Infectious Diseases (NIAID).

COMPLETED
Registry status
NA
Development phase
26 participants
Enrollment target

Study Summary

The purpose of this study is to collect and compare information on how and when adolescent heart transplant recipients take their prescribed medication. The investigators want to find out if regular use of 'an app' on cell phones, called the Teen Pocket PATH® (TPP), can help adolescents take their medication according to their prescribed dosing schedule. This may then help reduce complications of transplant, such as rejection. The investigators also want to find out if how adolescent heart transplant recipients take their medications affects the development of antibodies in their blood. Antibodies are small proteins in the blood that may develop after heart transplantation, and which can sometimes damage a new heart.

Interventions

  • OTHER Teen Pocket PATH® Mobile Application
  • OTHER Control Group: Standard of Care

Trial Details

FieldValue
Enrollment Target 26 participants
Start Date 2017-08-10
Est. Completion 2019-11-01
Phase NA

What the Registry Record Tells You About NCT02904278

The ClinicalTrials.gov registry entry for NCT02904278 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 26 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Institute of Allergy and Infectious Diseases (NIAID), which has 2,006 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Teen Pocket PATH® Mobile Application is the first listed.

NCT02904278 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT02904278 about?

NCT02904278 is a clinical study titled "Novel Mobile Device Application to Improve Adherence". The purpose of this study is to collect and compare information on how and when adolescent heart transplant recipients take their prescribed medication. The investigators want to find out if regular use of 'an app' on cell phones, called the Teen Pocket PATH® (TPP), can help adolescents take their m...

What is the current status of trial NCT02904278?

This trial is currently completed. It is a NA study. The enrollment target is 26 participants. The study started on 2017-08-10. Estimated completion is 2019-11-01.

What interventions are being tested in trial NCT02904278?

The interventions under investigation include: Teen Pocket PATH® Mobile Application (OTHER), Control Group: Standard of Care (OTHER).

Who is sponsoring clinical trial NCT02904278?

This trial is sponsored by National Institute of Allergy and Infectious Diseases (NIAID), which has 2,006 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.